Encephalitis, Japanese B Completed Phase 4 Trials for Japanese encephalitis vaccine (live, attenuated) (DB16577)

Also known as: Japanese Encephalitis / Encephalitis, Japanese / Encephalitis Japanese B / Japanese Encephalitis Virus Disease / Japanese B encephalitis / Japanese B viral encephalitis / Japanese encephalitis virus disease (disorder) / Arthropod-borne viral disease (& [dengue] or [Japanese encephalitis] or [yellow fever])

IndicationStatusPhase
DBCOND0033957 (Encephalitis, Japanese B)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02514746Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster DosePrevention
NCT02880865Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) VaccinePrevention
NCT01981967Post-licensure Safety Study of IMOJEVĀ® in ThailandPrevention